InvestorsHub Logo
Followers 20
Posts 3899
Boards Moderated 0
Alias Born 01/19/2005

Re: None

Sunday, 10/09/2016 10:07:44 PM

Sunday, October 09, 2016 10:07:44 PM

Post# of 15799
Not that this article about Zika is a big revenue source. I thought it was interesting. If this has been mentioned I apologize. Somehow I hadn't heard about it.

As locally transmitted cases of the Zika virus continue to emerge, a South Florida company is helping to develop a product that could be used globally to battle the threat.

Opko Health, a Miami-based pharmaceutical and diagnostics company founded by billionaire Dr. Phillip Frost, is playing a strategic role in helping to bring the first Zika vaccine to market. As a major shareholder of and an active strategic investor in Portland-based VBI Vaccines, Opko is guiding the development of a vaccine candidate that VBI CEO Jeff Baxter said could be widely available by 2019.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News